Viewing Study NCT03880695


Ignite Creation Date: 2025-12-24 @ 2:17 PM
Ignite Modification Date: 2026-02-21 @ 9:56 PM
Study NCT ID: NCT03880695
Status: UNKNOWN
Last Update Posted: 2019-03-21
First Post: 2019-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma
Sponsor: Peking University People's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module